Senescent Cells: Therapeutic Target, Biological Signal, or Red Herring? Longevity Series Brief Summary This article explores one of the most intriguing questions in modern geroscience: whether senescent cells are actionable therapeutic targets or merely biological bystanders associated with aging and chronic disease. The answer
Tag: fisetin
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies Introduction Approximately 80% of adults over age 65 worldwide develop at least one chronic condition, from arthritis to dementia. Recent longevity research has identified cellular senescence as a fundamental driver of age-related decline. These
